Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer
- 1 August 2019
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 45 (8) , 1410-1416
Abstract
No abstract availableKeywords
Funding Information
- “la Caixa” Foundation, Barcelona
- Alfonso Martín Escudero Foundation, Madrid
This publication has 35 references indexed in Scilit:
- Multi-Center Evaluation of Post-Operative Morbidity and Mortality after Optimal Cytoreductive Surgery for Advanced Ovarian CancerPLOS ONE, 2012
- Extended cytoreduction of tumor at the porta hepatis by an interdisciplinary team approach in patients with epithelial ovarian cancerGynecologic Oncology, 2011
- Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancerGynecologic Oncology, 2011
- Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resectionJournal of Surgical Oncology, 2011
- Quality of life among women after surgery for ovarian cancerPalliative and Supportive Care, 2008
- A new frontier for quality of care in gynecologic oncology surgery: Multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted modelGynecologic Oncology, 2007
- Quantitative prognostic indices in peritoneal carcinomatosisEuropean Journal of Surgical Oncology, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- What Are the Current Surgical Objectives, Strategies, and Technical Capabilities of Gynecologic Oncologists Treating Advanced Epithelial Ovarian Cancer?Gynecologic Oncology, 2001
- Ovarian Carcinoma Metastases to Gastrointestinal Tract Appear to Spread like Colon Carcinoma: Implications for Surgical ResectionGynecologic Oncology, 1995